Kairos Pharma, Ltd. Common Stock

Kairos Pharma, Ltd. Common Stock Share · US48301N1046 · KAPA (XNYS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Kairos Pharma, Ltd. Common Stock
Analyst Grade Summary
gauge-img
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
No Price
01.05.2026 20:33
Current Prices from Kairos Pharma, Ltd. Common Stock
ExchangeTickerCurrencyLast TradePriceDaily Change
XNYS: NYSE
NYSE
KAPA
USD
01.05.2026 20:33
0,59 USD
0,03 USD
+4,42 %
XASE: AMEX
AMEX
KAPA
USD
01.05.2026 19:53
0,58 USD
0,01 USD
+2,39 %
IEXG: IEX
IEX
KAPA
USD
30.04.2026 19:01
0,57 USD
0,02 USD
+3,26 %
Share Float & Liquidity
Free Float 41,89 %
Shares Float 8,97 M
Shares Outstanding 21,41 M
Company Profile for Kairos Pharma, Ltd. Common Stock Share
Kairos Pharma, Ltd. operates as a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients. Its therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. Kairos Pharma, Ltd. was formerly known as NanoGB13, Inc. and changed its name to Kairos Pharma, Ltd. in July 2016. The company was incorporated in 2013 and is based in Los Angeles, California.

Company Data

Name Kairos Pharma, Ltd. Common Stock
Company Kairos Pharma, Ltd.
Symbol KAPA
Website https://kairospharma.com
Primary Exchange XNYS NYSE
ISIN US48301N1046
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO John S. Yu
Market Capitalization 12 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 2355 Westwood Blvd., 90064 Los Angeles
IPO Date 2024-09-16

Ticker Symbols

Name Symbol
NYSE KAPA
More Shares
Investors who hold Kairos Pharma, Ltd. Common Stock also have the following shares in their portfolio:
DT.PFBR.BANK PF.R.15261
DT.PFBR.BANK PF.R.15261 Bond
WIIT 21/26
WIIT 21/26 Bond